The seroprevalence surveys, taking place in Conakry, Guinea, will describe the dynamic of the epidemic in the city.
Primary objective: To describe the dynamics of the SARS-CoV-2 epidemic in the city of Conakry, represented by the evolution over time of seroprevalence stratified by age group (under 15 years, 15-39 years and 40 years or more)
Type of study: Observational, seroprevalence surveys
Treatment tested: N/A
Number of sites: N/A
Sample size: 1400 per survey (5,200 in total)
Study participants: General population, resident of selected households
Study status: Not yet started
- Prof. Abdoulaye Toure, Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinée firstname.lastname@example.org
- Dr Jean-François Etard, Institut de Recherche pour le Développement, Montpelier, France email@example.com
- Study website
- Study ID: N/A
- Trial registry: N/A
Last updated: September 2020
Note that study-related documents posted on the COVID-19 Clinical Research Coalition (COVID-19 CRC) website have been shared by coalition members for information. Some may have been approved by Ethics Review Boards and others may still be in draft form. Documents posted here may have been further amended before being used in the conduct of the respective trials they were designed for. It is recommended that users review these documents carefully and, if they plan to use them, adapt them appropriately for their intended use. The COVID-19 CRC and its members cannot accept any liability for any claim, loss or damages as a result of any reliance placed on, or use of, these documents.